ArticleScientific reports2026
Overcoming multidrug resistance Acinetobacter baumanii via downregulated virulence factor genes by green fabricated silver Nanoparticles mediated Piper nigrum.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acinetobacter baumannii is a well-known pathogen that causes both community-acquired infections and nosocomial infections, particularly pneumonia associated with the use of ventilators. Numerous virulence factors and strong genomic plasticity are reported to be present in this opportunistic pathogen, which help it succeed in the infectious process. We aimed to study the inhibition and anti-biofilm abilities of the green-synthesized silver nanoparticles against the strain. Silver nanoparticles were green synthesized using the extract from Piper nigrum. Together with SEM, NTA, FTIR, XRD, and UV spectral analysis, the production of AgNPs was fully described. According to SEM and NTA examination, the produced NPs were in the 30–60 nm range. AgNPs were functionalized with organics in the reaction mixture, as indicated by FTIR measurements. Strong antibacterial and antibiofilm properties against MDR Acinetobacter baumanii were demonstrated by green-produced AgNPs. AgNP-treated isolates exhibited elevated ROS generation and membrane permeability. Antibacterial resistance was demonstrated by passaging the isolates for 15 generations. The positive control showed resistance after 13 generations, whereas the AgNPs demonstrated remarkable antimicrobial susceptibility even after 14 generations. We found a significant downregulation of all biofilm gene members in the study compared to the positive control (P < 0.05). These results highlight the potential for designing AgNPs for targeted future biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.